Šalis: Armėnija
kalba: anglų
Šaltinis: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
azelastine (azelastine hydrochloride)
MEDA Pharma GmbH & Co. KG
S01GX07
azelastine (azelastine hydrochloride)
0,5mg/ml
drops eye
6ml plastic vial-dropper
OTC
Registered
2016-09-24
SUMMARY OF PRODUCT CHARACTERISTICS /SPC 1. NAME OF THE MEDICINAL PRODUCT Allergodil eye drops. 0.5 mg / ml, Eye Drops, solution. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Azelastine hydrochloride 0.05% (0.5 mg/ml). Each drop contains 0.015 mg azelastine hydrochloride. Excipient: 1 ml contains 0.125 mg benzalkonium chloride. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Eye drops, solution. Clear, colourless solution. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment and prevention of the symptoms of seasonal allergic conjunctivitis in adults andchildren 4 years and older.Treatment of the symptoms of non-seasonal (perennial) allergic conjunctivitis in adults and children 12 years and older. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Seasonal allergic conjunctivitis: The usual dosage in adults and children 4 years and older is one drop in each eye twice daily that can be increased, if necessary to four times daily. If allergen exposure is anticipated Allergodil eye drops should be administered prophylactically, prior to the exposure. Non-seasonal (perennial) allergic conjunctivitis: The usual dosage in adults and children 12 years and older is one drop in each eye twice daily that can be increased, if necessary to four times daily. As safety and efficacy have been demonstrated in clinical trials for a period of up to 6 weeks, the duration of any course should be limited to a maximum of 6 weeks. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Allergodil Eye Drops is not intended for treatment of eye infections. Benzalkonium chloride may cause eye irritation. Contact with soft contact lenses should be avoided. Contact lenses should be removed prior to application and the patient should wait at least 15 minutes before reinsertion. Known to discolour soft contact lenses. 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION No specific interaction studies with Allergodil Perskaitykite visą dokumentą